BLUE trade ideas
Beautiful Setup on Bird - Longterm tradeLongterm trade - With Covid slowly fading and schools getting back to normal, Biden Admiinsteration, and electric buses, Bird right now is one of the major Bus manufacturers that are already manufacturing electric buses and selling them. Both fundemental and technical analysis.
BLUE - Good Buying Opportunity With 3.42B Market Cap Bluebird Bio after four years again on good level to Buy, Profit Target Primary 70-80 and secondary is 100-140.
You can take this stock from short term to long term.
Swing Trade: BLUE in Breakout modeHi guys,
Sharing one of my today swingtrades in healtcare on BLUE.
Nice setup for breakout.
If you like the idea, do not forget to support with a 👍 like and follow.
Leave a comment that is helpful or encouraging. Let's master the markets together.
BLUE Time to go Long?Will wait for break of downtrend to go long here. Should get confirmation next couple weeks.
BLUE: 98.5% institution ownership; 7.9 cash/debt; 100% upsideCheck out the fundamentals on BLUE! Can't possibly go wrong on this great stock! $55 per share is a bargain! Currently sitting on $1.5B cash with 195M debt-- a ratio of 7.9 cash/debt! AMAZING!
Bluebird Bio (BLUE) short.All description on the chart.
Please, don't forget to like and follow.
Thank you.
Only for investors : Biotech For those looking to diversify their portfolio or a long-term investment. Here I bring you an option in the biotech sector: Bluebird Bio INC, the leader in targeted cell therapy.
This stock is in an important support area. It is a zone where buyers will seek to accumulate to buy cheap. the risk in this operation is low compared to the profit potential
BIOTECH Bluebird BIOThe Stock stay very bullish, the volume increased strongly.
However the $72 level approaches. And it could be a good point of profit taking. Some corretions may come.
If break-out of the $72, then the $80 can be a good arrival point.
keep in touch!
Are you feeling blue?Shorterm trade for a reverse Head & Shoulders break out to $108. Mind the coming earning report date.
BLUE on downtrend.. next stop 37.5BLUE on downtrend.. next stop 37.5. Tread cautiously.. I would go short here. No position yet.
BlueBird inc. #BLUE2 Conditions on this stock:
2 Daily clousers over the level $143,11
Retest $140-$139
1) Buy-$140-$139
Stop loss-$137,67
Profit-$155-$160
2)Buy- $133,55-$131,27
Stop loss-$129,77
Profit-$145
Huge volatility expected in Bluebird Bio on Trial Data ReleaseThe options market is expecting huge moves tomorrow in the Bio company BLUE as the update investors on the trial data listed below. Keep strong watch there could be enormous volume in the coming days.
Phase 3 data for LentiGlobin in HGB-212 (transfusion-dependent beta thalassemia), June 14; updated Phase 1/2 data for LentiGlobin in HGB-204 (beta-thalassemia), June 14; updated Phase 3 data for LentiGlobin in HGB-207, June 14.
COMPANY PROFILE
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.
BLUEBIRD BIO INC - AWESOME TIME TO LONG THIS STORYAnother pharma company - with amazing correct Elliot 5 waves which you can try to ride.
1. Buy 131.32
2. Take profit: 213
3. SL: 115.90
RISK/REWARD: 5.38, potential profit 62.39%
BLUE: Don't trade this INVEST in it.This is one of the biggest name and Cell and Gene therapy area and sector is hot. This is very bullish and cannot be missed.
BLUE: May 17th: 180 calls
gl
